ACM
AVEO

AIGH Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

AIGH Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-695,358
Closed -$10.4M – 64
2022
Q4 		$10.4M Sell
695,358
-2,043,897
-75% -$28.3M 3.42% 13
2022
Q3 		$22.5M Sell
2,739,255
-208,339
-7% -$1.6M 7.01% 3
2022
Q2 		$19.3M Buy
2,947,594
+127,437
+5% +$617K 5.09% 4
2022
Q1 		$15.8M Buy
2,820,157
+263,557
+10% +$1.09M 3.87% 9
2021
Q4 		$12M Buy
2,556,600
+570,424
+29% +$3.54M 3.66% 10
2021
Q3 		$12.3M Buy
+1,986,176
New +$11.9M 2.58% 12

AIGH Capital Management's AVEO Position: Q1 2023 in Review

AIGH Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 695,358 shares — an estimated $10.4M sold.

AIGH Capital Management first reported a position in AVEO in Q3 2021 and held it in 6 quarters. The position peaked at $22.5M in Q3 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • AIGH Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • AIGH Capital Management sold 695,358 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $10.4M.
  • AIGH Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2021 and held it in 6 quarters.
  • AIGH Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $22.5M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on AIGH Capital Management's 13F filing for Q1 2023, filed 15 May 2023.